Overview
- The Dia D campaign runs this weekend with all health units open from 8 a.m. to 5 p.m. and drive-thru sites at Unesp campuses in Rubião Júnior and Fazenda Lageado.
- Botucatu received more than 80,000 doses and is targeting up to 50% coverage of people aged 15 to 59 today, with minors accompanied by a guardian and standard identification requested.
- Anvisa registered Butantan-DV on December 8 for use in people 12 to 59, marking the first single-dose dengue vaccine designed to generate antibodies to all four serotypes.
- Clinical studies reported roughly 75% efficacy against overall cases, over 91% against severe disease, and 100% against hospitalizations, with protection building in the weeks after vaccination.
- Botucatu was selected after its 2021 mass Covid-19 campaign, and partner cities Maranguape (CE) and Nova Lima (MG) began their dengue vaccinations on Saturday.